Moreover, the frequency of p16INK4α hypermethylation increased progressively from 17% in basal-cell hyperplasia to 24% in squamous metaplasia, and to 60% in squamous cell carcinomas [15]. This evidence concerns the gene CDKN2A and squamous cell carcinoma.